Boothbay Fund Management’s Kezar Life Sciences KZR Stock Holding History

Boothbay Fund Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,640	Closed	-$1.13M	–	2430
2022 Q2	$1.13M	Buy	13,640 +10,520	+337%	+$928K	0.03%	761
2022 Q1	$519K	Buy	3,120 +1,210	+63%	+$174K	0.01%	1270
2021 Q4	$319K	Buy	+1,910	New	+$216K	0.01%	1228

Boothbay Fund Management's KZR Position: Q2 2026 in Review

Boothbay Fund Management sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 16,210 shares — an estimated $120K sold.

Boothbay Fund Management first reported a position in KZR in Q4 2021 and held it in 18 quarters. The position peaked at $1.89M in Q4 2021. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Boothbay Fund Management reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Boothbay Fund Management sold 16,210 Kezar Life Sciences shares in Q2 2026, an estimated $120K.
Boothbay Fund Management first reported a position in Kezar Life Sciences in Q4 2021 and held it in 18 quarters.
Boothbay Fund Management's Kezar Life Sciences position peaked at $1.89M in Q4 2021.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.